Hypercoagulability, endothelial dysfunction (increased ICAM-1 levels), and inflammation (increased IL-6 levels) can still be detected in some patients approximately 1 year after recovery from COVID-19 [41]. The gene discussed is ICAM1; the disease is endothelial dysfunction.